Korean Circ J.  2012 Feb;42(2):118-121. 10.4070/kcj.2012.42.2.118.

Recurrent Very Late Stent Thrombosis in a Systemic Lupus Erythematous Patient

• Lee DY
• Park JP
• Ko SJ
• Lee SE
• Jhon SH
• Lim JH
• Rhew JY

• KMID: 1826384
• DOI: http://doi.org/10.4070/kcj.2012.42.2.118

Abstract

Coronary artery disease is the most important cause of mortality in patients with systemic lupus erythematous (SLE). After stenting for coronary artery disease in SLE patients similar to non-SLE patients, the risk of stent thrombosis is always present. Although there are reports of stent thrombosis in SLE patients, very late recurrent stent thrombosis is rare. We experienced a case of very late recurrent stent thrombosis (4 times) in a patient with SLE.

Keyword

Lupus erythematosus, systemic; Drug-eluting stents

MeSH Terms

Coronary Artery Disease
Drug-Eluting Stents
Humans
Lupus Erythematosus, Systemic
Stents
Thrombosis

Figure

• 

  Fig. 1 The first event of stent thrombosis. A: coronary angiogram showing total occlusion over the previous stent site of the mid LAD and the diagonal branch. B: coronary angiography after balloon angioplasty showing thrombolysis in myocardial infarction grade III flow of the LAD and moderate stenosis of the proximal LAD. LAD: left anterior descending artery.

• 

  Fig. 2 The second event of stent thrombosis. Coronary angiogram is showing good distal flow (thrombolysis in myocardial infarction III) after stent implantation in proximal left anterior descending artery with overlapping proximal part of the previous stent (arrow).

• 

  Fig. 3 The fourth event of stent thrombosis. A: coronary angiogram after balloon angioplasty showing multiple thrombi in the distal part of the stent and disease progression at the edge of stent. B and C: intravascular ultrasound finding is showing eccentric plaque with thrombi in the stent (B, arrow), and isoechoic plaque with significant stenosis at the distal edge of the stent (C, arrow). D: coronary angiogram showing good distal flow (thrombolysis in myocardial infarction III) after implantation of the stent in the distal part of the previous stent, overlapping the distal part of previous stent.

Reference

1. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematous: quantification of degree of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med. 1981. 70:775–781.

2. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003. 349:2399–2406.

3. Mehta PK, Samady H, Vassiliades TA, Book WM. Acute coronary syndrome as a first presentation of systemic lupus erythematosus in a teenager: revascularization by hybrid coronary artery bypass graft surgery and percutaneous coronary intervention: case report. Pediatr Cardiol. 2008. 29:957–961.

4. Kassaian SE, Goodarzynejad H, Darabian S, Basiri Z. Myocardial infarction secondary to premature coronary artery disease as the initial major manifestation of systemic lupus erythematous. Cardiovasc J Afr. 2008. 19:152–154.

5. Lee CH, Chong E, Low A, Lim J, Lme YT, Tan HC. Long-term follow-up after percutaneous coronary intervention in patients with systemic lupus erythematous. Int J Cardiol. 2008. 126:430–432.

6. Lee CH, Chan MY. Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus. Int J Cardiol. 2007. 114:e107–e108.

7. Olivier AC, Hollman JL. Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin. J Invasive Cardiol. 2006. 18:E185–E187.

8. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003. 82:299–308.

9. Moon YG, Kim YJ, Jeon DS, et al. A case of premature coronary atherosclerosis associated with systemic lupus erythematosus. Korean Circ J. 1995. 25:691–697.

10. Muir DF, Stevens A, Napier-Hemy RO, Fath-Ordoubadi F, Curzen N. Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma. Int J Cardiovasc Intervent. 2003. 5:44–46.

11. Su HM, Lee KT, Chu CS, Sheu SH, Lai WT. Acute thrombosis after elective direct intracoronary stenting in primary antiphospholipid syndrome: a case report. Kaohsiung J Med Sci. 2003. 19:177–182.

12. Lee KH, Lee SW, Lee JW, et al. The significance of clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the verifynow p(2)y(12) assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation. Korean Circ J. 2009. 39:512–518.

13. Lee CW, Kang SJ, Park DW, et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol. 2010. 55:1936–1942.